Stay updated on BMN 111 in Achondroplasia Children Clinical Trial
Sign up to get notified when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.

Latest updates to the BMN 111 in Achondroplasia Children Clinical Trial page
- ChecktodayChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check65 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase 3 study for BMN 111 as a treatment for Achondroplasia, including eligibility criteria and study design. The only notable addition is the revision number, which indicates a version update.SummaryDifference25%
Stay in the know with updates to BMN 111 in Achondroplasia Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.